Multiplex array proteomics detects increased MMP-8 in CSF after spinal cord injury

Journal of Neuroinflammation

Stephen JA Davies²  Kyle H Jasper²  Peter DeWitt¹  Kenneth H Minor²  Matthew Light² 

[1] Colorado Biostatistics Consortium, Department of Biostatistics and Informatics, University of Colorado Denver, 12477 E 19th Avenue, Room 102, Aurora, CO, 80045, USA;Department of Neurosurgery, University of Colorado School of Medicine, Building RC-1 North, Room P18-9400, 12800 E 19th Avenue, Aurora, CO, 80045, USA

关键词: tissue inhibitor of metalloproteinase-1 (TIMP-1).;    spinal cord injury;    proteomics;    microarray;    matrix metalloproteinase-8 (MMP-8);    inflammation;    cytokine;    cerebrospinal fluid (CSF);    biomarker;   

Others  :  1212537
DOI  :  10.1186/1742-2094-9-122

 received in 2011-11-23, accepted in 2012-05-04,  发布年份 2012

【 授权许可】

   
2012 Light et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]National Spinal Cord Injury Statistical Center: Spinal cord injury: facts and figures at a glance. J Spinal Cord Med 2005, 28:379-380.
• [2]Miniño AM: Death in the United States, 2009. NCHS data brief, no. 64. National Center for Health Statistics, Hyattsville, MD; 2011. http://www.cdc.gov/nchs/data/databriefs/db64.pdf webcite
• [3]van den Berg ME, Castellote JM, de Pedro-Cuesta J, Mahillo-Fernandez I: Survival after spinal cord injury: a systematic review. J Neurotrauma 2010, 27:1517-1528.
• [4]Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC: The cellular inflammatory response in human spinal cords after injury. Brain: J Neurol 2006, 129:3249-3269.
• [5]Leal-Filho MB: Spinal cord injury: from inflammation to glial scar. Surg Neurol Int 2011, 2:112.
• [6]Yang L, Jones NR, Blumbergs PC, Van Den Heuvel C, Moore EJ, Manavis J, Sarvestani GT, Ghabriel MN: Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J Clin Neurosci 2005, 12:276-284.
• [7]Blight AR: Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 1992, 9(Suppl. 1):S83-S91.
• [8]Pruss H, Kopp MA, Brommer B, Gatzemeier N, Laginha I, Dirnagl U, Schwab JM: Non-Resolving Aspects of Acute Inflammation after Spinal Cord Injury (SCI): Indices and Resolution Plateau. Brain Pathol 2011, 21:652-660.
• [9]Cohen DM, Patel CB, Ahobila-Vajjula P, Sundberg LM, Chacko T, Liu SJ, Narayana PA: Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI. NMR Biomed 2009, 22:332-341.
• [10]Ankeny DP, Popovich PG: Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience 2009, 158:1112-1121.
• [11]Fehlings MG, Hawryluk GW: Scarring after spinal cord injury. J Neurosurg Spine 2010, 13:165-167. discussion 167–168
• [12]Silver J, Miller JH: Regeneration beyond the glial scar. Nat Rev Neurosci 2004, 5:146-156.
• [13]Gensel JC, Donnelly DJ, Popovich PG: Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Exp Opin Therapeutic Targets 2011, 15:505-518.
• [14]Kwon BK, Casha S, Hurlbert RJ, Yong VW: Inflammatory and structural biomarkers in acute traumatic spinal cord injury. Clin Chem Lab Med: CCLM/FESCC 2011, 49:425-433.
• [15]Reiber H: Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 1998, 4:99-107.
• [16]Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, Ngai KL, Lui GC, Wong BC, Lee SK, Choi KW, Hui DSC: Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS One 2011, 6:e26050.
• [17]Mizutani T, Akasaka R, Tomita K, Chiba T: Serial changes of cytokines in Crohn's disease treated with infliximab. Hepatogastroenterol 2011, 58(110–111):1523-1526.
• [18]Tefferi A, Vaidya R, Caramazza D, Finke C, Lasho T, Pardanani A: Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. J Clin Oncol 2011, 29:1356-1363.
• [19]Nielsen UB, Geierstanger BH: Multiplexed sandwich assays in microarray format. J Immunol Methods 2004, 290:107-120.
• [20]Pang S, Smith J, Onley D, Reeve J, Walker M, Foy C: A comparability study of the emerging protein array platforms with established ELISA procedures. J Immunol Methods 2005, 302:1-12.
• [21]Benjamini Y, Hochburg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B (Methodol) 1995, 57:289-300.
• [22]Hsueh HM, Chen JJ, Kodell RL: Comparison of methods for estimating the number of true null hypotheses in multiplicity testing. J Biopharm Stat 2003, 13:675-689.
• [23]Zhao M, Wang X, Nolte D: Mass-transport limitations in spot-based microarrays. Biomed Opt Express 2010, 1:983-997.
• [24]Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT: Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 1998, 152:74-87.
• [25]Wang CX, Olschowka JA, Wrathall JR: Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res 1997, 759:190-196.
• [26]Kwon BK, Stammers AM, Belanger LM, Bernardo A, Chan D, Bishop CM, Slobogean GP, Zhang H, Umedaly H, Giffin M, Street J, Boyd MC, Paquette SJ, Fisher CG, Dvorak MF: Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J Neurotrauma 2010, 27:669-682.
• [27]Lubieniecka JM, Streijger F, Lee JH, Stoynov N, Liu J, Mottus R, Pfeifer T, Kwon BK, Coorssen JR, Foster LJ, Grigliatti TA, Tetzlaff W: Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats. PLoS One 2011, 6:e19247.
• [28]RayBiotech, Inchttp://www.raybiotech.com webcite(November 12, 2011)
• [29]Team RDC: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria; 2011.
• [30]Pinheiro J, Bates D, DebRoy S, Sarkar D, nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1-102 edition. R Foundation for Statistical Computing, Vienna, Austria; 2011.
• [31]Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ: Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433-447.
• [32]De Castro RC, Burns CL, McAdoo DJ, Romanic AM: Metalloproteinase increases in the injured rat spinal cord. NeuroReport 2000, 11:3551-3554.
• [33]Wells JE, Rice TK, Nuttall RK, Edwards DR, Zekki H, Rivest S, Yong VW: An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci 2003, 23:10107-10115.
• [34]Veeravalli KK, Dasari VR, Tsung AJ, Dinh DH, Gujrati M, Fassett D, Rao JS: Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. Neurobiol Dis 2009, 36:200-212.
• [35]Leivonen SK, Chantry A, Hakkinen L, Han J, Kahari VM: Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways. J Biol Chem 2002, 277:46338-46346.
• [36]Kim ES, Kim MS, Moon A: TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 2004, 25:1375-1382.
• [37]Cuadrado E, Rosell A, Penalba A, Slevin M, Alvarez-Sabin J, Ortega-Aznar A, Montaner J: Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 2009, 8:3191-3197.